Atle Fund Management AB Diversified Active

Location: Stockholm, Sweden

CIK: 0001381843 · Show all filings

Period: Q3 2022 (← Previous) (Next →)

Filing Date: Oct 21, 2022

Total Value: $47.34M (100.0% shares, 0.0% debt)

Holdings (10)

UTMD UTAH MED PRODS INC 15.5%

Value $7.337M Shares 86,000 Est. Cost $87.95 Unrealized +0.4%

BMY BRISTOL-MYERS SQUIBB CO 14.7%

Value $6.967M Shares 98,000 Est. Cost $56.60 Unrealized +10.1%

GILD GILEAD SCIENCES INC 13.7%

Value $6.477M Shares 105,000 Est. Cost $55.43 Unrealized +0.6%

CI CIGNA CORP NEW 10.0%

Value $4.717M Shares 17,000 Est. Cost $226.54 Unrealized +16.9%

ZVRA KEMPHARM INC 9.9%

Value $4.68M Shares 750,000 Est. Cost $5.29 Unrealized +7.1%

CAH CARDINAL HEALTH INC 9.9%

Value $4.668M Shares 70,000 Est. Cost $59.26 Unrealized 0.0%

MCK MCKESSON CORP 9.3%

Value $4.418M Shares 13,000 Est. Cost $235.19 Unrealized +45.1%

VTRS VIATRIS INC 8.6%

Value $4.09M Shares 480,000 Est. Cost $8.98 Unrealized -6.2%

— OPIANT PHARMACEUTICALS INC 4.8%

Value $2.258M Shares 210,000 Est. Cost $12.80 Unrealized —

AUPH AURINIA PHARMACEUTICALS INC 3.7%

Value $1.73M Shares 230,000 Est. Cost $11.18 Unrealized -22.6%

Ticker	Issuer	Shares	Value	%	Est. Cost	Unrealized	Class	CUSIP
UTMD	UTAH MED PRODS INC	86,000	$7.337M	15.5%	$87.95	+0.4%	COM	917488108
BMY	BRISTOL-MYERS SQUIBB CO	98,000	$6.967M	14.7%	$56.60	+10.1%	COM	110122108
GILD	GILEAD SCIENCES INC	105,000	$6.477M	13.7%	$55.43	+0.6%	COM	375558103
CI	CIGNA CORP NEW	17,000	$4.717M	10.0%	$226.54	+16.9%	COM	125523100
ZVRA	KEMPHARM INC	750,000	$4.68M	9.9%	$5.29	+7.1%	COM NEW	488445206
CAH	CARDINAL HEALTH INC	70,000	$4.668M	9.9%	$59.26	0.0%	COM	14149Y108
MCK	MCKESSON CORP	13,000	$4.418M	9.3%	$235.19	+45.1%	COM	58155Q103
VTRS	VIATRIS INC	480,000	$4.09M	8.6%	$8.98	-6.2%	COM	92556V106
—	OPIANT PHARMACEUTICALS INC	210,000	$2.258M	4.8%	$12.80	—	COM	683750103
AUPH	AURINIA PHARMACEUTICALS INC	230,000	$1.73M	3.7%	$11.18	-22.6%	COM	05156V102